André Tapp

Sleep and mental disorders: A meta-analysis of polysomnographic research.

Altered fecal microbiota composition in patients with major depressive disorder

Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence

Benefits and Risks of Antipsychotic Polypharmacy

The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements

Transdermal oestrogen for treatment of severe postnatal depression

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance

Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association

Medication Compliance and Persistence: Terminology and Definitions

Puberty and depression: the roles of age, pubertal status and pubertal timing

Estradiol-17β increase serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain

Cognitive skills associated with estrogen replacement in women with Alzheimer's disease

Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters

Puberty onset of gender differences in rates of depression: a developmental, epidemiologic and neuroendocrine perspective

Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects

Potential mechanisms of atypical antipsychotic-induced metabolic derangement: Clues for understanding obesity and novel drug design

Effects of Gonadal Steroids in Women With a History of Postpartum Depression

Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour

Ghrelin: Structure and Function

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

Estrogen Actions in the Central Nervous System¹

Results of a naturalistic study of treatment options: Switching atypical antipsychotic drugs or augmenting with valproate

Hypocretin (OREXIN): Role in Normal Behavior and Neuropathology

Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus

Schizophrenia and Other Psychotic Disorders

Melatonin, energy metabolism, and obesity: a review

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

Effects of age and pubertal status on depression in a large clinical sample

Religion, Spirituality, and Health: The Research and Clinical Implications

Kynurenine pathway in psychosis: evidence of increased tryptophan degradation

Depression in Kraepelinian schizophrenia

Special Section on CATIE Baseline Data: Baseline Use of Concomitant Psychotropic Medications to Treat Schizophrenia in the CATIE Trial

Schizophrenia, narcolepsy, and HLA-DR15, DQ6

Combination Antipsychotic Therapy in Clinical Practice

Olanzapine-Induced Weight Gain and Increased Visceral Adiposity is Blocked by Melatonin Replacement Therapy in Rats

Concomitant Psychotropic Medication Use During Treatment of Schizophrenia Patients: Longitudinal Results from the CATIE Study

EFFECT OF OESTROGEN AND TESTOSTERONE IMPLANTS ON PSYCHOLOGICAL DISORDERS IN THE CLIMACTERIC

Baseline Use of Concomitant Psychotropic Medications to Treat Schizophrenia in the CATIE Trial